Jeffrey McIndoo

Pleaded guilty and sentenced. McIndoo admitted the charge by plea to an information; his company pleaded guilty to a smuggling conspiracy and was ordered shuttered.

Introduction

Jeffrey McIndoo, of Phoenix, Arizona, is the owner and operator of SARMS Pharm who was sentenced to four months in prison and a $1,000 fine as the Justice Department announced that his company was ordered to cease operations and forfeit $1.8 million for the illicit sale of selective androgen receptor modulators — SARMs — chemical substances that mimic the effects of anabolic steroids and are not approved by the U.S. Food and Drug Administration . The October 21, 2026, sentencing followed prior guilty pleas to an information .

Background Information

SARMs — selective androgen receptor modulators — mimic the effects of anabolic steroids when ingested into the body and are not approved by the FDA, which classifies them among the potentially dangerous chemical substances sold outside its safeguards . McIndoo ran SARMS Pharm under JeffMac Investments LLC doing business as SARMS Pharm LLC . Between 2017 and 2022, the company earned gross profits totaling at least $3.5 million from selling SARMs — unapproved drugs sold to customers chasing the muscle-building effects of anabolic steroids without a legal path to them .

The Controversy or Incident That Led to Their Cancellation

McIndoo admitted to introducing an unapproved drug into interstate commerce, and SARMS Pharm pleaded guilty to a conspiracy to smuggle SARMs from China into the United States . As part of its plea, the company agreed to forfeit $1.8 million of the proceeds it retained from the scheme . Judge Sharad H. Desai of the District of Arizona sentenced McIndoo and also ordered SARMS Pharm shuttered — a corporate death sentence layered on top of the forfeiture .

Public Reaction and Consequences

Assistant Attorney General Brett A. Shumate of the Justice Department’s Civil Division said: “By smuggling and selling unapproved SARMs, the defendants circumvented important federal safeguards designed to protect public health,” adding that the sentence shows those who enrich themselves through illegal sales of potentially dangerous products “will be held accountable” . The case was investigated by the FDA’s Office of Criminal Investigations and prosecuted by Managing Attorney David Sullivan and Assistant Director Patrick Runkle of the Civil Division’s Enforcement & Affirmative Litigation Branch .

Current Status

McIndoo is serving his four-month sentence, and SARMS Pharm is out of business by court order with $1.8 million forfeited to the government . The outcome — a short personal sentence paired with the forced closure of the company itself — reflects the Civil Division’s use of corporate plea agreements to shut down the underlying business rather than only punishing the individual behind it .

Impact on Their Career/Life

McIndoo’s case closes the books on one of the better-known corners of the online SARMs market: a Phoenix company whose five-year run moved at least $3.5 million in unapproved performance-enhancing chemicals before the FDA’s criminal investigators and a corporate guilty plea ended it. The judgment leaves McIndoo a convicted drug-introducer whose entire business — the brand, the China supply line, the $1.8 million it kept — has been dissolved by court order.

Sources

• DOJ Office of Public Affairs, “Illicit SARMS Dealer Sentenced and His Company Ordered to Cease Operations and Forfeit $1.8M,” October 21, 2026 — source